Katz Richard D 4
4 · ARGOS THERAPEUTICS INC · Filed Apr 2, 2018
Insider Transaction Report
Form 4
Katz Richard D
VP & Chief Financial Officer
Transactions
- Award
Common Stock
2018-03-28+22,629→ 32,326 total
Footnotes (1)
- [F1]The shares are subject to a lapsing right of repurchase by the issuer, which shall lapse as to 11,315 shares on June 15, 2018, and with respect to the remaining 11,314 shares on December 14, 2018, subject to the Reporting Person continuing to be an employee of the issuer through each such date.